miRecule

RNA Therapeutics

Gaithersburg, United States · Founded 2016 · $11.2M raised

Headquarters
Gaithersburg
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$11.2M
Last Round
$2.4M GrantSep 2024
Rounds
5

About

miRecule is a clinical-stage biotechnology company based in Gaithersburg, Maryland, that develops RNA-based therapeutics, including Antibody RNA Conjugate (ARC) drugs, for rare neuromuscular diseases and cancer. Its proprietary DREAmiR platform mines genomic and outcome data from thousands of patients to identify disease-driving genetic changes and design RNA therapeutics that directly target them, with lead programs in Facioscapulohumeral Muscular Dystrophy (FSHD) and Head & Neck Squamous Cell Carcinoma (HNSCC). Founded in 2016, the company has formed strategic collaborations with Sanofi and EMS Group's Rio Biopharma to advance delivery of its RNA therapeutics.

Summary

miRecule is a Biotech company based in Gaithersburg, United States, founded in 2016. It has raised $11.2M in total across 5 rounds, most recently a $2.4M Grant round in Sep 2024. Investors include Alexandria Venture Investments, Alumni Ventures and Boutique Venture Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Sep 2024
$2.4M

Sign up to see all 5 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

miRecule on Indexed.vc
<a href="https://indexed.vc/companies/mirecule"><img src="https://indexed.vc/api/badge/company/mirecule" alt="miRecule on Indexed.vc" width="260" height="76" /></a>